HTA: References

Health Technology Assessment on the Net:
professional development by distance

References

[1] Baines CJ. 1993. Critiquing the national breast screening study: creative misinformation builds barriers to the dissemination of research findings. British Columbia Office of Health Technology Assessment Newsletter 4:2-4.

[2] Banta HD. 1987. Clinical and epidemiological research on new technologies: a role for economic appraisal? In Economic appraisal of health technology in the European Community, ed. Drummond MF, 93-102. Oxford: Oxford University Press.

[3] Banta HD, Andreasen PB. 1990. The political dimension in health care technology assessment programs. Int J Technol Assess Health Care 6(1):115-123.

[4] Banta HD, Behney CJ, Willems JS. 1981. Toward rational technology in medicine: considerations for health policy. New York: Springer.

[5] Banta HD, Thacker SB. 1990. The case for reassessment of health care technology; once is not enough. JAMA July 11, 264(2):235-240.

[6] Duplicate reference deleted.

[7] Bloom DF; Cornhill JF; Malchesky PS; Richardson DM; Bolsen KA; Haire DM; Loop FD; Cosgrove DM. 1997. Technical and economic feasibility of reusing disposable perfusion cannulae. Biomed Instrum Technol May-Jun;31(3):248-9.

[8] Bos M. 1988. Making decisions about medical technology: the need for information. In Expensive health technologies: regulatory and administrative mechanisms in Europe, ed. Stocking B, pp. 60-65. Oxford: Oxford University Press.

[9] British Columbia Ministry of Health and Ministry Responsible for Seniors. 1996. Framework for monitoring and reporting regional health outcomes: a guide for regional health boards . Principal author, Dr. Kimberley McEwan. Victoria, B.C.: Queen's Printer 956.PS.PS.491, 03/96. Full text available electronically at this website.

[10] British Columbia Ministry of Health and Ministry Responsible for Seniors. 1996. Health service outcome reporting: a guide for health agencies . Principal author, Dr. Malcolm Maclure. Victoria, B.C.: Queen's Printer 967.PS.PS.064, 08/96. Full text available electronically at this website.

[11] British Columbia Ministry of Health and Ministry Responsible for Seniors. 1997. Myths and facts about BC's Reference Drug Program . Victoria, BC: Queen's Printer 318822, 978-CH.PC051 07/97. Full text available electronically at this website.

[12] BC Office of Health Technology Assessment (Green CJ, Bassett K, Foerster V, Kazanjian A). 1997. Bone mineral density testing: does the evidence support its selective use in well women? Vancouver, BC Office of Health Technology Assessment, BCOHTA 97:2T.

[13] BC Office of Health Technology Assessment (Bassett K, Kazanjian A). 1996. Incorporating clinical effectiveness debates into hospital technology assessment: the case of laser treatment of benign prostatic hyperplasia. Vancouver, BC Office of Health Technology Assessment, BCOHTA 96:1D. Full text available electronically at this website and the report can be viewed or downloaded in pdf format here

[14] Browne KF; Maldonado R; Telatnik M; Vlietstra RE; Brenner AS. 1997. Initial experience with reuse of coronary angioplasty catheters in the United States. J Am Coll Cardiol;30(7):1735-40.

[15] Buxton MJ. 1987. Problems in the economic appraisal of new health technology: the evaluation of heart transplants in the UK. In Economic appraisal of health technology in the European Community, ed. Drummond MF, pp. 103-118. Oxford: Oxford University Press.

[16] Buxton MJ, Drummond MF, van Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M. 1997. Modelling in economic evaluation: an unavoidable fact of life. Health Economics 6:217-227.

[17] Canadian Coordinating Office for Health Technology Assessment. 1996. A guidance document for the costing process, Version 1.0. Ottawa: Canadian Coordinating Office for Health Technology assessment.

[18] Canadian Coordinating Office for Health Technology Assessment. 1997. Guidelines for economic evaluation of pharmaceuticals: Canada, 2nd ed. Ottawa: Canadian Coordinating Office for Health Technology assessment.

[19] Canadian Healthcare Association (CHA). 1996. The re-use of single-use medical devices: guidelines for healthcare facilities. Ottawa: CHA Press.

[20] Chalmers I. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci 1993; 703:156-65.

[21] Chalmers I, Altman DG, eds. 1995. Systematic reviews. London: British Medical Journal Publishing Group.

[22] Chalmers TC. 1981. The clinical trial. Milbank Memorial Fund Quarterly 59(3):324-339.

[23] Chalmers TC. 1974. The impact of clinical trials on the practice of medicine. Mount Sinai Journal of Medicine 301:44-45.

[24] Chalmers TC. 1975. Randomization of the first patient. Medical clinics of North America 59:1035-1038.

[25] Conseil d'évaluation des technologies de la santé (CETS). 1994. The impact of renal extracorporeal shock-wave lithotripsy on the use of resources in the Quebec health care system. Montreal: CÉTS.

[26] Conseil d'évaluation des technologies de la santé (CETS). 1995. The introduction of laparoscopic cholescystectomy in Quebec: effects on intervention rates and resource utilization. Montreal: CÉTS, report 97-4 RE.

[27] Conseil d'évaluation des technologies de la santé (CETS). 1993. The reuse of single-use catheters. Montreal: CÉTS, report 23a.

[28] Conseil d'évaluation des technologies de la santé (CETS). 1997. The reuse of single-use catheters and the risk of transmission of Creutzfeld-Jakob. Montreal: CÉTS, report 97-4 RE.

[29] Culyer AJ, Horisberger B. 1983. Medical and economic evaluation: a postscript. In Economic and medical evaluation of health care technologies, eds. Culyer AJ, Horisberger B, pp. 347-58. Berlin: Springer-Verlag.

[30] Dickersin K, Herxheimer A. 1996. Introduction: the quality of the medical evidence: is it good enough? Int J Technol Assess Health Care 12(2):187-189.

[31] Dickersin K, Min YI. 1993. Publication bias: the problem that won't go away. Ann NY Acad Sci 703:135-148.

[32] Drummond MF. 1980. Principles of economic appraisal in health care. Oxford: Oxford University Press.

[33] Drummond MF. 1981. Welfare economics and cost benefit analysis in health care. Scottish J Polit Econ 28(2):125-145.

[34] Drummond MF. 1986. Guidelines for health technology assessment: economic evaluation. In Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 107-127. Montreal: Institute for Research on Public Policy.

[35] Drummond MF. 1987. Methods for economic appraisal of health technology. In Economic appraisal of health technology in the European Community, ed. Drummond MF, pp. 15-48. Oxford: Oxford University Press.

[36] Drummond MF. Allocating resources. 1990. Int J Technol Assess Health Care 6(1):77-92.

[37] Drummond MF, Brandt A, Luce B, Rovira J. 1993. Standardizing methodologies for economic evaluation in health care. Int J Technol Assess Health Care 9(1):25-36.

[38] Drummond MF, Davies L. 1991. Economic analysis alongside clinical trials: revisiting the methodological issues. Int J Technol Assess Health Care 7(4):561-73.

[39] Drummond MF, Ludbrook A, Lowson K, Steele A. 1986. Studies in economic appraisal in health care: volume 2. Oxford: Oxford University Press.

[40] Drummond MF, O'Brien BJ, Stoddart GL, Torrance G. 1997. Methods for the Economic Evaluation of Health Care Programmes, Second Edition. Oxford: Oxford University Press. Can be ordered via the Internet at: http://www4.oup.co.uk/isbn/0-19-262773-2

[41] Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. 1997. Users' guides to the medical literature: XIII. How to use an article on economic analysis of clinical practice: A. Are the results of the study valid? JAMA 21 May 97, 277(19):1552-1557.

[42] Drummond MF, Stoddart GL. 1984. Economic analysis and clinical trials. Controlled Clinical Trials 5:115-128.

[43] Drummond MF, Stoddart GL, Torrance GW. 1987. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.

[44] Dyer AR, Stamler J, Paul O, Lepper M, Shekelle RB, McKean H, Garside D. 1980. Alcohol consumption and 17-year mortality in the Chicago Western Electric Company Study. Prev Med 9:78-90.

[45] Evans RG. 1984. Strained mercy: the economics of Canadian health care. Toronto: Butterworths.

[46] Evans RG, Robinson GC. 1980. Surgical day care: measurements of the economic payoff. Can Med Assoc J 123:873-880.

[47] Feeny D, Guyatt G, Tugwell P, Eds. 1986. Foreward, Preface, Summary, Chapter 1 , in Health care technology: effectiveness, efficiency, and public policy. Full text available electronically at this website.

[48] Feeny D. 1986. New health care technologies: their effect on health and the cost of health care. Chapter 2 , in Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 5-24. Montreal: Institute for Research on Public Policy. Full text available electronically at this website.

[49] Feeny D. 1986. The diffusion of new health care technologies. In Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 25-40. Montreal: Institute for Research on Public Policy.

[50] Gafni A, Birch S. 1991. Equity considerations in utility-based measures of health outcomes in economic appraisals: an adjustment algorithm. J Health Economics 10:329-342.

[51] Gotzsche PC, Liberati A, Torri V, Rossetti L. 1996. Beware of surrogate outcome measures. Int J Technol Assess Health Care 12(2):238-246.

[52] Grinshaw JM, Russell IT. 1993. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317-1322.

[53] Guyatt GH, van Zanten Veldhuqzen VZ, Feeny DH, Patrick DL. 1989. Measuring quality of life in clinical trials: a taxonomy and review. CMAJ 140(12):1441-1448.

[54] Hatziandreu EE, Carlson K, Mulley AG Jr, Weinstein MC. 1990. Cost-effectiveness study of the extracorporeal shock-wave lithotriptor. Int J Technol Assess Health Care 6(4):623-632.

[55] Haynes RB, Hayward RSA, Lomas J. 1995. Bridges between health care research evidence and clinical practice. J Amer Med Informatics Assoc 2(6):342-350.

[56] Hirsch N, Hailey D. 1995. The evolution of laparoscopic surgery in routine health care. Int J Technol Assess Health Care 11(4):779-785.

[57] Juzwishin DWM. 1995. Case Study: Assessing laparoscopic cholecystectomy, the GVHS experience. Int J Technol Assess Health Care 11(4): 685-694.

[58] Juzwishin D, Olmstead D, Menon D. 1996. Hospital-based technology assessment programmes: two Canadian examples. World Hospitals and Health Services 32(2): 2-9.

[59] Klarman HE. 1981. Measuring economic effects of biomedical innovation. In Biomedical innovation, eds. Roberts EB, Levy RI, Finkelstein SN, Moskowitz J, Sondik EJ, 219-253. Cambridge, Mass: MIT Press.

[60] Lambert EC. 1978. Modern Medical Mistakes. Bloomington, IN: Indiana Univ Press.

[61] Lau J. Chalmers TC. 1995. The rational use of therapeutic drugs in the 21st century. Int J Technol Assess Health Care 11(3):509-522.

[62] Laupacis A, Feeny D, Detsky AS, Tugwell P. 1992. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J; 146(4):473-481.

[63] Lewis S, Naylor D, Battista R, Champagne F, Lomas J, Menon D, Ross E, de Vlieger D. 1998. Canada needs an evidence-based decision-making trade show. CMAJ 27 Jan; 158(2), 210-212.

[64] Lipsey RG, Purvis DD, Steiner PO. 1988. Economics (6th edition). New York: Harper & Row.

[65] Lomas J. 1988. Holding back the tide of cesareans: publishing recommendations is not enough to stop the rise. Brit Med J 297:569-570.

[66] Lomas J. 1993. Making clinical policy explicit: legislative policy making and lessons for developing practice guidelines. Int J Technol Assess Health Care 9(1):11-25.

[67] Lomas J, Enkin M, Anderson GM et al. 1991. Opinion leaders versus audit and feedback to implement practice guidelines: delivery after previous cesarean section. JAMA 265-2202-2207.

[68] Lomas J, Sisk JE, Stocking B. 1993. From evidence to practice in the United States, the United Kingdom, and Canada. Milbank Quarterly 71(3):405-410.

[69] Luce BR, Elixhauser A. 1990. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 6(1):57-75.

[70] Lumley J, Bastian H. 1996. Competing or complementary: ethical considerations and the quality of randomized trials. Int J Technol Assess Health Care 12(2):247-263.

[71] Maclure, M. 1996. Health Services Outcome Reporting: Boston Marathon '96 Medical Outcomes Study. (video) Copyright M. Maclure.

[72] Maclure M, Potashnik TM. 1997. What is direct evidence-based policy-making? Experience from the drug benefits program for seniors in British Columbia. Can J Aging/Can Public Policy Suppl. 132-146.

[73] Marshall D, Hailey D, Hirsch N, Clark E, Menon D. 1994. The introduction of laparoscopic cholecystectomy in Canada and Australia. Ottawa: Canadian Coordinating Office for Health Technology assessment.

[74] Marshall D, Olog J, Wedel H. 1996. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (312):1254-59 (full text online at http://www.bmj.com/cgi/content/full/312/7041/1254

[75] Mason J, Drummond M, Torrance G. 1993. Some guidelines on the use of cost effectiveness league tables. BMJ 27 Feb, 306:570-572.

[76] McKinlay JB. 1981. From "promising report" to "standard procedure": seven stages in the career of a medical innovation. Milbank Memorial Fund Quarterly 59(3):374-411.

[77] Mehrez A, Gafni A. 1991. The healthy-years equivalents: how to measure them using the standard gamble approach. Med Decision Making 11(2):140-146.

[78] Mooney GH. Equity in health care: confronting the confusion. Effective Health Care 1983 1(4):179-185.

[79] National Library of Medicine, Medical subject headings (MeSH) from PubMed, MeSH browser, at: http://www.ncbi.nlm.nih.gov/Entrez/index.html.

[80] O'Brien BJ, Hayland D, Richardson WS, Levine M, Drummond MF. 1997. Users' guides to the medical literature: XIII. How to use an article on economic analysis of clinical practice: B. What are the results and will they help me in caring for my patients? JAMA 11 June 97, 277(22):1802-1806.

[81] Office of Technology Assessment, Congress of the United States. 1980. The Implications of Cost-Effectiveness Analysis of Medical Technology. Washington, D.C.: U.S. Government Printing Office

[82] Pearce DW. 1978. The valuation of social cost. London: George Allen & Unwin.

[83] Rice DP, Cooper BS. 1967. The economic value of human life. Amer J Public Health 57(11):1954-1966.

[84] Sackett DL, Richardson WS, Rosenberg WMC, Haynes RB. 1997. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone.

[85] Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. 1996. Evidence-based medicine: what it is and what it isn't. BMJ 312: 71-72.

[86] Samuelson PA. 1973. Economics (9th edition). New York: McGraw-Hill.

[87] Spilker B, ed. 1996. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia: Lippincott-Raven.

[88] Stoddart GL, Drummond MF. 1984. How to read clinical journals: VII. To understand an economic evaluation (parts A and B). Can Med Assoc J 130:1428-1434 and 1542-1549.

[89] Stolley PD. 1996. Generations of misplaced confidence. Int J Technol Assess Health Care 12(2):190-194.

[90] Tengs, TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD. 1995. Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis 15(3):369-390.

[91] Thomas CL, ed. 1985. Taber's cyclopedic medical dictionary. Philadelphia: F.A. Davis, p. 725.

[92] Torrance GW, Feeny D. 1989. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 5:559-575.

[93] Tugwell P, Bennett K, Feeny D, Guyatt G, Haynes RB. 1986. A framework for the evaluation of technology: the technology assessment iterative loop. In Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 41-56. Montreal: Institute for Research on Public Policy.

[94] Tugwell P, Sitthi-Amorn C, O'Connor A, Hatcher-Roberts J, Bergevin Y, Wolfson M. 1995 Technology assessment: old, new, and needs-based. Int J Technol Assess Health Care 11(4):650-662.

[95] Warburton RN. 1988. Digital diagnostic imaging at Victoria General Hospital: preliminary economic results. Victoria: British Columbia Ministry of Health.

[96] Warburton RN. 1995. Methodological problems in the economic appraisal of emerging health care technology. Ph.D. thesis, University of London: London, England.

[97] Warner KE, Luce BR. 1982. Cost-benefit and cost-effectiveness analysis in health care. Ann Arbor, Michigan: Health Administration Press.

[98] Weinstein M, Stason W. 1977. Foundations of cost-effectiveness analysis for health and medical practices. New Engl J Med 296(13):716-721.

[99]
Weisbrod BA. 1968. Income redistribution effects and benefit-cost analysis. In Problems in public expenditure analysis, ed. Chase SB, 177-209. Washington, D.C.: Brookings Institution. Reprinted as Deriving an implicit set of government weights for income classes. In Cost-benefit analysis: selected readings, ed. Layard R, 395-428. Harmondsworth, Middlesex: Penguin, 1972 reprinted 1977.

[100] Wilkin TJ. 1999. Changing perceptions in osteoporosis. BMJ 27 March 1999, 318: 862-865.(Full text online at
http://www.bmj.com/cgi/content/full/318/7187/862#resp1 .)

[101] Williams A. 1983. The role of economics in the evaluation of health care technologies. In Economic and medical evaluation of health care technologies, eds. Culyer AJ, Horisberger B, pp. 38-68. Berlin: Springer-Verlag.

[102] Williams A. 1992. Cost-effectiveness analysis: is it ethical? J Medical Ethics 18(1):7-11.

Return to HTA Home

Send mail to htaprof@uvic.ca with questions or comments about this web site.
Copyright © 1998 Rebecca N. Warburton and School of Health Information Science, University of Victoria
Last modified: January 10, 2002

[1]	Baines CJ. 1993. Critiquing the national breast screening study: creative misinformation builds barriers to the dissemination of research findings. British Columbia Office of Health Technology Assessment Newsletter 4:2-4.
[2]	Banta HD. 1987. Clinical and epidemiological research on new technologies: a role for economic appraisal? In Economic appraisal of health technology in the European Community, ed. Drummond MF, 93-102. Oxford: Oxford University Press.
[3]	Banta HD, Andreasen PB. 1990. The political dimension in health care technology assessment programs. Int J Technol Assess Health Care 6(1):115-123.
[4]	Banta HD, Behney CJ, Willems JS. 1981. Toward rational technology in medicine: considerations for health policy. New York: Springer.
[5]	Banta HD, Thacker SB. 1990. The case for reassessment of health care technology; once is not enough. JAMA July 11, 264(2):235-240.
[6]	Duplicate reference deleted.
[7]	Bloom DF; Cornhill JF; Malchesky PS; Richardson DM; Bolsen KA; Haire DM; Loop FD; Cosgrove DM. 1997. Technical and economic feasibility of reusing disposable perfusion cannulae. Biomed Instrum Technol May-Jun;31(3):248-9.
[8]	Bos M. 1988. Making decisions about medical technology: the need for information. In Expensive health technologies: regulatory and administrative mechanisms in Europe, ed. Stocking B, pp. 60-65. Oxford: Oxford University Press.
[9]	British Columbia Ministry of Health and Ministry Responsible for Seniors. 1996. Framework for monitoring and reporting regional health outcomes: a guide for regional health boards . Principal author, Dr. Kimberley McEwan. Victoria, B.C.: Queen's Printer 956.PS.PS.491, 03/96. Full text available electronically at this website.
[10]	British Columbia Ministry of Health and Ministry Responsible for Seniors. 1996. Health service outcome reporting: a guide for health agencies . Principal author, Dr. Malcolm Maclure. Victoria, B.C.: Queen's Printer 967.PS.PS.064, 08/96. Full text available electronically at this website.
[11]	British Columbia Ministry of Health and Ministry Responsible for Seniors. 1997. Myths and facts about BC's Reference Drug Program . Victoria, BC: Queen's Printer 318822, 978-CH.PC051 07/97. Full text available electronically at this website.
[12]	BC Office of Health Technology Assessment (Green CJ, Bassett K, Foerster V, Kazanjian A). 1997. Bone mineral density testing: does the evidence support its selective use in well women? Vancouver, BC Office of Health Technology Assessment, BCOHTA 97:2T.
[13]	BC Office of Health Technology Assessment (Bassett K, Kazanjian A). 1996. Incorporating clinical effectiveness debates into hospital technology assessment: the case of laser treatment of benign prostatic hyperplasia. Vancouver, BC Office of Health Technology Assessment, BCOHTA 96:1D. Full text available electronically at this website and the report can be viewed or downloaded in pdf format here
[14]	Browne KF; Maldonado R; Telatnik M; Vlietstra RE; Brenner AS. 1997. Initial experience with reuse of coronary angioplasty catheters in the United States. J Am Coll Cardiol;30(7):1735-40.
[15]	Buxton MJ. 1987. Problems in the economic appraisal of new health technology: the evaluation of heart transplants in the UK. In Economic appraisal of health technology in the European Community, ed. Drummond MF, pp. 103-118. Oxford: Oxford University Press.
[16]	Buxton MJ, Drummond MF, van Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M. 1997. Modelling in economic evaluation: an unavoidable fact of life. Health Economics 6:217-227.
[17]	Canadian Coordinating Office for Health Technology Assessment. 1996. A guidance document for the costing process, Version 1.0. Ottawa: Canadian Coordinating Office for Health Technology assessment.
[18]	Canadian Coordinating Office for Health Technology Assessment. 1997. Guidelines for economic evaluation of pharmaceuticals: Canada, 2nd ed. Ottawa: Canadian Coordinating Office for Health Technology assessment.
[19]	Canadian Healthcare Association (CHA). 1996. The re-use of single-use medical devices: guidelines for healthcare facilities. Ottawa: CHA Press.
[20]	Chalmers I. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci 1993; 703:156-65.
[21]	Chalmers I, Altman DG, eds. 1995. Systematic reviews. London: British Medical Journal Publishing Group.
[22]	Chalmers TC. 1981. The clinical trial. Milbank Memorial Fund Quarterly 59(3):324-339.
[23]	Chalmers TC. 1974. The impact of clinical trials on the practice of medicine. Mount Sinai Journal of Medicine 301:44-45.
[24]	Chalmers TC. 1975. Randomization of the first patient. Medical clinics of North America 59:1035-1038.
[25]	Conseil d'évaluation des technologies de la santé (CETS). 1994. The impact of renal extracorporeal shock-wave lithotripsy on the use of resources in the Quebec health care system. Montreal: CÉTS.
[26]	Conseil d'évaluation des technologies de la santé (CETS). 1995. The introduction of laparoscopic cholescystectomy in Quebec: effects on intervention rates and resource utilization. Montreal: CÉTS, report 97-4 RE.
[27]	Conseil d'évaluation des technologies de la santé (CETS). 1993. The reuse of single-use catheters. Montreal: CÉTS, report 23a.
[28]	Conseil d'évaluation des technologies de la santé (CETS). 1997. The reuse of single-use catheters and the risk of transmission of Creutzfeld-Jakob. Montreal: CÉTS, report 97-4 RE.
[29]	Culyer AJ, Horisberger B. 1983. Medical and economic evaluation: a postscript. In Economic and medical evaluation of health care technologies, eds. Culyer AJ, Horisberger B, pp. 347-58. Berlin: Springer-Verlag.
[30]	Dickersin K, Herxheimer A. 1996. Introduction: the quality of the medical evidence: is it good enough? Int J Technol Assess Health Care 12(2):187-189.
[31]	Dickersin K, Min YI. 1993. Publication bias: the problem that won't go away. Ann NY Acad Sci 703:135-148.
[32]	Drummond MF. 1980. Principles of economic appraisal in health care. Oxford: Oxford University Press.
[33]	Drummond MF. 1981. Welfare economics and cost benefit analysis in health care. Scottish J Polit Econ 28(2):125-145.
[34]	Drummond MF. 1986. Guidelines for health technology assessment: economic evaluation. In Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 107-127. Montreal: Institute for Research on Public Policy.
[35]	Drummond MF. 1987. Methods for economic appraisal of health technology. In Economic appraisal of health technology in the European Community, ed. Drummond MF, pp. 15-48. Oxford: Oxford University Press.
[36]	Drummond MF. Allocating resources. 1990. Int J Technol Assess Health Care 6(1):77-92.
[37]	Drummond MF, Brandt A, Luce B, Rovira J. 1993. Standardizing methodologies for economic evaluation in health care. Int J Technol Assess Health Care 9(1):25-36.
[38]	Drummond MF, Davies L. 1991. Economic analysis alongside clinical trials: revisiting the methodological issues. Int J Technol Assess Health Care 7(4):561-73.
[39]	Drummond MF, Ludbrook A, Lowson K, Steele A. 1986. Studies in economic appraisal in health care: volume 2. Oxford: Oxford University Press.
[40]	Drummond MF, O'Brien BJ, Stoddart GL, Torrance G. 1997. Methods for the Economic Evaluation of Health Care Programmes, Second Edition. Oxford: Oxford University Press. Can be ordered via the Internet at: http://www4.oup.co.uk/isbn/0-19-262773-2
[41]	Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. 1997. Users' guides to the medical literature: XIII. How to use an article on economic analysis of clinical practice: A. Are the results of the study valid? JAMA 21 May 97, 277(19):1552-1557.
[42]	Drummond MF, Stoddart GL. 1984. Economic analysis and clinical trials. Controlled Clinical Trials 5:115-128.
[43]	Drummond MF, Stoddart GL, Torrance GW. 1987. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
[44]	Dyer AR, Stamler J, Paul O, Lepper M, Shekelle RB, McKean H, Garside D. 1980. Alcohol consumption and 17-year mortality in the Chicago Western Electric Company Study. Prev Med 9:78-90.
[45]	Evans RG. 1984. Strained mercy: the economics of Canadian health care. Toronto: Butterworths.
[46]	Evans RG, Robinson GC. 1980. Surgical day care: measurements of the economic payoff. Can Med Assoc J 123:873-880.
[47]	Feeny D, Guyatt G, Tugwell P, Eds. 1986. Foreward, Preface, Summary, Chapter 1 , in Health care technology: effectiveness, efficiency, and public policy. Full text available electronically at this website.
[48]	Feeny D. 1986. New health care technologies: their effect on health and the cost of health care. Chapter 2 , in Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 5-24. Montreal: Institute for Research on Public Policy. Full text available electronically at this website.
[49]	Feeny D. 1986. The diffusion of new health care technologies. In Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 25-40. Montreal: Institute for Research on Public Policy.
[50]	Gafni A, Birch S. 1991. Equity considerations in utility-based measures of health outcomes in economic appraisals: an adjustment algorithm. J Health Economics 10:329-342.
[51]	Gotzsche PC, Liberati A, Torri V, Rossetti L. 1996. Beware of surrogate outcome measures. Int J Technol Assess Health Care 12(2):238-246.
[52]	Grinshaw JM, Russell IT. 1993. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317-1322.
[53]	Guyatt GH, van Zanten Veldhuqzen VZ, Feeny DH, Patrick DL. 1989. Measuring quality of life in clinical trials: a taxonomy and review. CMAJ 140(12):1441-1448.
[54]	Hatziandreu EE, Carlson K, Mulley AG Jr, Weinstein MC. 1990. Cost-effectiveness study of the extracorporeal shock-wave lithotriptor. Int J Technol Assess Health Care 6(4):623-632.
[55]	Haynes RB, Hayward RSA, Lomas J. 1995. Bridges between health care research evidence and clinical practice. J Amer Med Informatics Assoc 2(6):342-350.
[56]	Hirsch N, Hailey D. 1995. The evolution of laparoscopic surgery in routine health care. Int J Technol Assess Health Care 11(4):779-785.
[57]	Juzwishin DWM. 1995. Case Study: Assessing laparoscopic cholecystectomy, the GVHS experience. Int J Technol Assess Health Care 11(4): 685-694.
[58]	Juzwishin D, Olmstead D, Menon D. 1996. Hospital-based technology assessment programmes: two Canadian examples. World Hospitals and Health Services 32(2): 2-9.
[59]	Klarman HE. 1981. Measuring economic effects of biomedical innovation. In Biomedical innovation, eds. Roberts EB, Levy RI, Finkelstein SN, Moskowitz J, Sondik EJ, 219-253. Cambridge, Mass: MIT Press.
[60]	Lambert EC. 1978. Modern Medical Mistakes. Bloomington, IN: Indiana Univ Press.
[61]	Lau J. Chalmers TC. 1995. The rational use of therapeutic drugs in the 21st century. Int J Technol Assess Health Care 11(3):509-522.
[62]	Laupacis A, Feeny D, Detsky AS, Tugwell P. 1992. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J; 146(4):473-481.
[63]	Lewis S, Naylor D, Battista R, Champagne F, Lomas J, Menon D, Ross E, de Vlieger D. 1998. Canada needs an evidence-based decision-making trade show. CMAJ 27 Jan; 158(2), 210-212.
[64]	Lipsey RG, Purvis DD, Steiner PO. 1988. Economics (6th edition). New York: Harper & Row.
[65]	Lomas J. 1988. Holding back the tide of cesareans: publishing recommendations is not enough to stop the rise. Brit Med J 297:569-570.
[66]	Lomas J. 1993. Making clinical policy explicit: legislative policy making and lessons for developing practice guidelines. Int J Technol Assess Health Care 9(1):11-25.
[67]	Lomas J, Enkin M, Anderson GM et al. 1991. Opinion leaders versus audit and feedback to implement practice guidelines: delivery after previous cesarean section. JAMA 265-2202-2207.
[68]	Lomas J, Sisk JE, Stocking B. 1993. From evidence to practice in the United States, the United Kingdom, and Canada. Milbank Quarterly 71(3):405-410.
[69]	Luce BR, Elixhauser A. 1990. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 6(1):57-75.
[70]	Lumley J, Bastian H. 1996. Competing or complementary: ethical considerations and the quality of randomized trials. Int J Technol Assess Health Care 12(2):247-263.
[71]	Maclure, M. 1996. Health Services Outcome Reporting: Boston Marathon '96 Medical Outcomes Study. (video) Copyright M. Maclure.
[72]	Maclure M, Potashnik TM. 1997. What is direct evidence-based policy-making? Experience from the drug benefits program for seniors in British Columbia. Can J Aging/Can Public Policy Suppl. 132-146.
[73]	Marshall D, Hailey D, Hirsch N, Clark E, Menon D. 1994. The introduction of laparoscopic cholecystectomy in Canada and Australia. Ottawa: Canadian Coordinating Office for Health Technology assessment.
[74]	Marshall D, Olog J, Wedel H. 1996. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (312):1254-59 (full text online at http://www.bmj.com/cgi/content/full/312/7041/1254
[75]	Mason J, Drummond M, Torrance G. 1993. Some guidelines on the use of cost effectiveness league tables. BMJ 27 Feb, 306:570-572.
[76]	McKinlay JB. 1981. From "promising report" to "standard procedure": seven stages in the career of a medical innovation. Milbank Memorial Fund Quarterly 59(3):374-411.
[77]	Mehrez A, Gafni A. 1991. The healthy-years equivalents: how to measure them using the standard gamble approach. Med Decision Making 11(2):140-146.
[78]	Mooney GH. Equity in health care: confronting the confusion. Effective Health Care 1983 1(4):179-185.
[79]	National Library of Medicine, Medical subject headings (MeSH) from PubMed, MeSH browser, at: http://www.ncbi.nlm.nih.gov/Entrez/index.html.
[80]	O'Brien BJ, Hayland D, Richardson WS, Levine M, Drummond MF. 1997. Users' guides to the medical literature: XIII. How to use an article on economic analysis of clinical practice: B. What are the results and will they help me in caring for my patients? JAMA 11 June 97, 277(22):1802-1806.
[81]	Office of Technology Assessment, Congress of the United States. 1980. The Implications of Cost-Effectiveness Analysis of Medical Technology. Washington, D.C.: U.S. Government Printing Office
[82]	Pearce DW. 1978. The valuation of social cost. London: George Allen & Unwin.
[83]	Rice DP, Cooper BS. 1967. The economic value of human life. Amer J Public Health 57(11):1954-1966.
[84]	Sackett DL, Richardson WS, Rosenberg WMC, Haynes RB. 1997. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone.
[85]	Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. 1996. Evidence-based medicine: what it is and what it isn't. BMJ 312: 71-72.
[86]	Samuelson PA. 1973. Economics (9th edition). New York: McGraw-Hill.
[87]	Spilker B, ed. 1996. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia: Lippincott-Raven.
[88]	Stoddart GL, Drummond MF. 1984. How to read clinical journals: VII. To understand an economic evaluation (parts A and B). Can Med Assoc J 130:1428-1434 and 1542-1549.
[89]	Stolley PD. 1996. Generations of misplaced confidence. Int J Technol Assess Health Care 12(2):190-194.
[90]	Tengs, TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD. 1995. Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis 15(3):369-390.
[91]	Thomas CL, ed. 1985. Taber's cyclopedic medical dictionary. Philadelphia: F.A. Davis, p. 725.
[92]	Torrance GW, Feeny D. 1989. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 5:559-575.
[93]	Tugwell P, Bennett K, Feeny D, Guyatt G, Haynes RB. 1986. A framework for the evaluation of technology: the technology assessment iterative loop. In Health care technology: effectiveness, efficiency, and public policy, eds. Feeny D, Guyatt G, Tugwell P, pp. 41-56. Montreal: Institute for Research on Public Policy.
[94]	Tugwell P, Sitthi-Amorn C, O'Connor A, Hatcher-Roberts J, Bergevin Y, Wolfson M. 1995 Technology assessment: old, new, and needs-based. Int J Technol Assess Health Care 11(4):650-662.
[95]	Warburton RN. 1988. Digital diagnostic imaging at Victoria General Hospital: preliminary economic results. Victoria: British Columbia Ministry of Health.
[96]	Warburton RN. 1995. Methodological problems in the economic appraisal of emerging health care technology. Ph.D. thesis, University of London: London, England.
[97]	Warner KE, Luce BR. 1982. Cost-benefit and cost-effectiveness analysis in health care. Ann Arbor, Michigan: Health Administration Press.
[98]	Weinstein M, Stason W. 1977. Foundations of cost-effectiveness analysis for health and medical practices. New Engl J Med 296(13):716-721.
[99]	Weisbrod BA. 1968. Income redistribution effects and benefit-cost analysis. In Problems in public expenditure analysis, ed. Chase SB, 177-209. Washington, D.C.: Brookings Institution. Reprinted as Deriving an implicit set of government weights for income classes. In Cost-benefit analysis: selected readings, ed. Layard R, 395-428. Harmondsworth, Middlesex: Penguin, 1972 reprinted 1977.
[100]	Wilkin TJ. 1999. Changing perceptions in osteoporosis. BMJ 27 March 1999, 318: 862-865.(Full text online at http://www.bmj.com/cgi/content/full/318/7187/862#resp1 .)
[101]	Williams A. 1983. The role of economics in the evaluation of health care technologies. In Economic and medical evaluation of health care technologies, eds. Culyer AJ, Horisberger B, pp. 38-68. Berlin: Springer-Verlag.
[102]	Williams A. 1992. Cost-effectiveness analysis: is it ethical? J Medical Ethics 18(1):7-11.